Genital Diseases, Female: Clinical Trials

11,189 trials for Genital Diseases, Female, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5181 completed, 2061 unknown, 1542 recruiting, 840 terminated. 3194 Not applicable, 2641 Phase 2, 1765 Phase 1, 1051 Phase 3, 498 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3194Completed 1472, Unknown 639, Recruiting 495, Not yet recruiting 196, Active not recruiting 143, Terminated 141, Withdrawn 71, Enrolling by invitation 31, Suspended 6
Phase 22641Completed 1184, Recruiting 361, Unknown 343, Terminated 339, Active not recruiting 160, Not yet recruiting 128, Withdrawn 115, Suspended 8, Enrolling by invitation 3
Phase 11765Completed 795, Recruiting 269, Terminated 264, Unknown 177, Active not recruiting 126, Withdrawn 72, Not yet recruiting 43, Suspended 15, Enrolling by invitation 4
Phase 31051Completed 537, Unknown 167, Recruiting 124, Terminated 83, Active not recruiting 62, Not yet recruiting 38, Withdrawn 34, Suspended 5, Enrolling by invitation 1
Phase 4498Completed 273, Unknown 118, Terminated 33, Recruiting 24, Not yet recruiting 22, Withdrawn 18, Active not recruiting 7, Enrolling by invitation 2, Suspended 1
Early Phase 1178Completed 73, Unknown 34, Recruiting 16, Terminated 16, Withdrawn 14, Active not recruiting 12, Not yet recruiting 10, Enrolling by invitation 2, Suspended 1

Follow Genital Diseases, Female: new trials by email Literature Review of Genital Diseases, Female trials Research Report on Genital Diseases, Female

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
Exercise and dietary recommendations - Ovarian Cancer
Not applicableNot yet recruitingOncare Madrid322028-05-012026-10-08
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders
Ginger, Placebo - Women With Coagulation Disorders
Early Phase 1Not yet recruitingUniversity of Valladolid742028-02-012026-05-19
Perioperative Esketamine Safety and Efficacy in Reducing Postoperative ENDometriosis PAIN (the ENDPAIN Trial): a Randomized Controlled Trial.
Esketamine, Placebo - Endometriosis
Phase 4Not yet recruitingRegion Skane10002028-01-012026-10-19
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity
Povidone-iodine 5% solution - Cesarean Section, Surgical Site Infection
Not applicableNot yet recruitingMohamed Mousa Mohamed Mousa6002027-05-012026-07-20
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer
Not applicableNot yet recruitingBoston Medical Center800002027-05-012025-11-10
Appendectomy as an Adjunct Procedure in Endometriosis Surgery
Appendectomy, Standard of Care (SOC) - Endometriosis
Not applicableNot yet recruitingMount Sinai Hospital, Canada2402027-04-012026-09-16
Topical Curcumin for HPV Related Cervical Disease
Curcumin C3 Complex, Placebo - Neoplasm Cervix
Phase 2Not yet recruitingLisa Flowers2002027-04-012026-05-08
PITCH - Impacting Hereditary Cancer Testing
Genetic testing education video - Ovarian Cancer, Genetic Testing
Not applicableNot yet recruitingRachel Miller2002027-04-012026-09-10
Cancer Awareness Among Syrian Migrants
PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening
Not applicableNot yet recruitingToros University302027-03-092026-10-15
The Effect of Preoperative Pelvic Floor Physical Therapy (Prehabilitation) on Postoperative Pain Following Endometriosis Surgery: A Randomized Controlled Trial
Structured pre-operative pelvic floor physiotherapy program (prehabilitation) - Endometriosis, Chronic Pelvic Pain
Not applicableNot yet recruitingUniversity of Alberta1502027-03-012026-09-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma
Phase 4Not yet recruitingMayo Clinic202027-02-122026-08-05
A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment
metronidazole (MTZ)+ LCFA-01 placebo + LC103 placebo, metronidazole (MTZ)+ LCFA-01 + LC103 placebo, metronidazole (MTZ)+ LC103 + LCFA-01 placebo - Bacterial Vaginosis
Phase 1Not yet recruitingMassachusetts General Hospital2802027-02-032026-10-15
Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis
Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis)
Phase 2Not yet recruitingMedical University of Vienna602027-02-012026-09-18
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
losartan, Paclitaxel - Platinum Resistant Ovarian Cancer
Phase 2Not yet recruitingMassachusetts General Hospital272027-02-012026-09-22
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Time-Restricted Eating as a Dietary Intervention for Polyendocrine Metabolic Ovarian Syndrome (PMOS): Protocol for a Randomized Controlled Trial
Time-restricted eating - Polycystic Ovary Syndrome
Not applicableNot yet recruitingJoanna Bajerska842027-01-092026-10-16
My Self-Sampling for HPV Awareness, Results, and Empowerment
MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening
Not applicableNot yet recruitingDaisy Le1302027-01-012026-08-18
NK521 in the Treatment of Advanced Solid Tumors
NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer
Early Phase 1Not yet recruitingBase Therapeutics (Shanghai) Co., Ltd.182027-01-012026-09-30
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Semaglutide (Wegovy) weekly injection, LNG-IUD (Progestin), Structured Weight Loss Program - Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
Phase 2Not yet recruitingThe Methodist Hospital Research Institute482027-01-012026-10-01

Showing 20 of 11189. Sign in to see all of them.

Narrower conditions

Ovarian Neoplasms (3258)  ·  Uterine Cervical Neoplasms (2241)  ·  Endometrial Neoplasms (1387)  ·  Polycystic Ovary Syndrome (949)  ·  Endometriosis (885)  ·  Breast Neoplasms (848)  ·  Fallopian Tube Neoplasms (827)  ·  Carcinoma, Ovarian Epithelial (784)  ·  Infertility, Female (538)  ·  Neoplasms (537)  ·  Carcinoma, Non-Small-Cell Lung (432)  ·  Colorectal Neoplasms (432)  ·  Uterine Cervical Dysplasia (383)  ·  Pancreatic Neoplasms (375)  ·  Stomach Neoplasms (343)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (11186)  ·  Female Urogenital Diseases (11181)  ·  Urogenital Diseases (11180)  ·  Genital Diseases (11179)  ·  Neoplasms (7460)  ·  Neoplasms by Site (6610)  ·  Urogenital Neoplasms (6591)  ·  Genital Neoplasms, Female (6539)  ·  Adnexal Diseases (5073)  ·  Endocrine System Diseases (5016)  ·  Gonadal Disorders (4959)  ·  Ovarian Diseases (4916)  ·  Uterine Diseases (4336)  ·  Endocrine Gland Neoplasms (3721)

Interventions

Paclitaxel (533)  ·  Carboplatin (504)  ·  Cisplatin (319)  ·  Bevacizumab (257)  ·  pembrolizumab (223)  ·  Metformin (197)  ·  Gemcitabine (153)  ·  Topotecan (130)  ·  Cyclophosphamide (124)  ·  liposomal doxorubicin (124)  ·  Surveys and Questionnaires (119)  ·  olaparib (116)  ·  Radiotherapy (107)  ·  Letrozole (101)  ·  Blood Specimen Collection (95)

Sponsors

National Cancer Institute (NCI) (280)  ·  M.D. Anderson Cancer Center (175)  ·  Gynecologic Oncology Group (146)  ·  Memorial Sloan Kettering Cancer Center (122)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (84)  ·  AstraZeneca (81)  ·  GlaxoSmithKline (77)  ·  Assiut University (73)  ·  Cairo University (66)  ·  Bayer (63)  ·  Merck Sharp & Dohme LLC (62)  ·  Peking Union Medical College Hospital (59)  ·  Mayo Clinic (58)  ·  University Health Network, Toronto (57)  ·  Lei Li (55)

Countries

United States (4101)  ·  China (1279)  ·  France (753)  ·  Italy (701)  ·  Canada (645)  ·  Spain (551)  ·  United Kingdom (528)  ·  Germany (415)  ·  Belgium (391)  ·  South Korea (367)  ·  Turkey (Türkiye) (359)  ·  Egypt (346)  ·  Australia (302)  ·  Netherlands (285)  ·  Denmark (242)

Top investigators

Lei Li, M.D. (40)  ·  Paul Sabbatini, MD (15)

Results publications

PMID 37185961, PMID 37407274, PMID 41276263, PMID 35170751, PMID 34878624, PMID 27008889, PMID 36971688, PMID 37462232, PMID 39695768, PMID 40966692, PMID 19238149, PMID 26972555, PMID 29476499, PMID 30633128, PMID 36396498, PMID 16394300, PMID 20818904, PMID 23922302, PMID 25968836, PMID 26961146, PMID 28525302, PMID 29342393, PMID 29486615, PMID 30380365, PMID 32379297, PMID 32621325, PMID 32779730, PMID 32945631, PMID 33538338, PMID 33650259, PMID 33963686, PMID 35289396, PMID 35537408, PMID 36357960, PMID 36512649, PMID 37619252, PMID 39019698, PMID 40709601, PMID 41044356, PMID 41166720, PMID 41868592, PMID 42693220, PMID 12834941, PMID 14688154, PMID 15105384, PMID 18158291, PMID 19236277, PMID 19236279, PMID 19935017, PMID 20097333

NIH funding

U10CA027469 (95), 2023 (67), U10CA180868 (67), 2018 (42), 2017 (41), 2025 (41), 2016 (33), 2019 (33), 2009 (26), 2008 (24), 2015 (24), P30CA033572 (21), 2014 (20), P30CA016672 (20), U10CA101165 (18)